The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Moiseev V.S.

Kafedra fakul'tetskoĭ terapii RUDN

Kobalava Zh.D.

Rossiĭskiĭ universitet druzhby narodov, Moskva

Clinical pharmacology and pharmacotherapy: Problems and disputable issues

Authors:

Moiseev V.S., Kobalava Zh.D.

More about the authors

Journal: Therapeutic Archive. 2015;87(8): 4‑8

Read: 3941 times


To cite this article:

Moiseev VS, Kobalava ZhD. Clinical pharmacology and pharmacotherapy: Problems and disputable issues. Therapeutic Archive. 2015;87(8):4‑8. (In Russ.)
https://doi.org/10.17116/terarkh20158784-8

References:

  1. Yudin S.S. Vospominaniya. M.: Izdatel'skii dom TONChU; 2012:688.
  2. Chazov E.I. Zdorov'e i vlast'. M.: GEOTAR-Media; 2009:496.
  3. Genno-inzhenernye biologicheskie preparaty v lechenii revmatoidnogo artrita. Pod red. Nasonova E.L. M.: IMA-Press; 2013:552.
  4. Hoofnagle J, Seeff L. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med. 2006;355:2444-2451.
  5. Bacon B, Gordon S, Lawitz E., Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R for the HCV RESPOND-2 Investigators Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364:1207-1217. doi:10.1056/nejmoa1009482.
  6. Jacobson I, Mchutchison J, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S for the ADVANCE Study Team Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl JMed. 2011;364:2405. doi:10.1056/nejmoa1012912.
  7. Cooper L, Knowlton K. Myocarditis. In: Mann D, ed. Braunwald’s Heart Disease. Elsevier; 2015:1589-1602.
  8. Pankuveit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev. 2013;18:683-702.  doi: 10.1007/s10741-012-9357-4.
  9. Gupalo EM, Buryachkovskaya LI, Golytsyn S, Balan M, Opavsky MA. Coxsackie-adenovirus receptor (CAR) in patients with cardiomyopathy of inflammatory and non-inflammatory etiology. Eur J Heart Fail. 2013;1(15):602.  doi:10.1016/j.yjmcc.2011.02.011.
  10. Pokrovskii V.I., Pak S.G., Briko N.I. Danilkin B.K. Infektsionnye bolezni i epidemiologiya. Uchebnik. M.: GEOTAR-Media; 2004:295.
  11. Fisher S, Lipshultz S. Cardiovascular abnormalities in HIV-infected individuals. In: Mann D, ed. Braunwald’s Heart Disease. Elsevier; 2015:1624-1635.
  12. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995-2002.
  13. Hess OM, McKenna W, Schultheiss HP. Myocardial diseases. In: Camm AJ, Leischer TF, eds. The ESC Textbook of Cardiovascular Medicine. Serruys PW; Blackwell Publ., Ljuljana: Blackwell Publ; 2006:453-515.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.